Walgreens Boots Alliance (NASDAQ:WBA) Releases FY 2024 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 2.800-2.950 for the period, compared to the consensus estimate of 3.200. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY24 guidance to $2.80-$2.95 EPS.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on WBA shares. UBS Group reduced their price objective on Walgreens Boots Alliance from $22.00 to $17.00 and set a neutral rating for the company in a research note on Monday. Barclays dropped their price objective on Walgreens Boots Alliance from $21.00 to $19.00 and set an underweight rating on the stock in a report on Monday. Bank of America dropped their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an underperform rating on the stock in a report on Tuesday, March 26th. TD Cowen dropped their price objective on Walgreens Boots Alliance from $37.00 to $35.00 and set a buy rating on the stock in a report on Wednesday, April 3rd. Finally, Raymond James reissued a market perform rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of Hold and an average target price of $23.07.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $12.04 on Friday. Walgreens Boots Alliance has a 52 week low of $11.68 and a 52 week high of $31.32. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $10.39 billion, a P/E ratio of -1.74, a P/E/G ratio of 0.98 and a beta of 0.78. The stock’s fifty day moving average is $16.72 and its two-hundred day moving average is $20.33.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.04). Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. During the same quarter in the prior year, the firm earned $1.00 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 2.8% compared to the same quarter last year. Equities analysts expect that Walgreens Boots Alliance will post 3.21 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were paid a $0.25 dividend. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.31%. Walgreens Boots Alliance’s payout ratio is presently -14.29%.

Insider Activity

In related news, Director Inderpal S. Bhandari bought 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now owns 3,000 shares in the company, valued at approximately $54,150. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.